Increase walking distance and endurance

Trial ID
NCT06859528
Official Title
Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
Goal
Increase walking distance and endurance
Phase
NA
Status
RECRUITING
Sponsor
St. Louis University
Study Type
INTERVENTIONAL
Enrollment
40 participants
Conditions
Parkinson Disease, Parkinson Disease, Idiopathic
Interventions
Community Walking Program

Summary For Families

The goal is to help people with Parkinson's improve walking, balance, and endurance so daily activities feel easier and fall risk may be reduced. The approach is a community walking program that uses regular, structured group walks to gradually increase walking time, pace, and aerobic fitness, which can improve gait, stamina, and balance through repeated practice and social support. The study seeks adults 30 to 85 with a neurologist diagnosis of Parkinson's who can walk independently with or without a cane or walker and are willing to commit about six months, excluding people with health problems that limit exercise such as heart issues, uncontrolled blood pressure, exercise-induced asthma, another neurologic disease, significant cognitive impairment, or very poor walking ability.

Locations

  • Integrated Health and Movement Science Laboratory, Saint Louis University, St Louis, Missouri, United States

Frequently Asked Questions

What is this trial testing?
This trial is studying Community Walking Program. The goal is to help people with Parkinson's improve walking, balance, and endurance so daily activities feel easier and fall risk may be reduced. The approach is a community walking program that uses regular, structured group walks to gradually increase walking time, pace, and aerobic fitness, which can improve gait, stamina, and balance through repeated practice and social support. The study seeks adults 30 to 85 with a neurologist diagnosis of Parkinson's who can walk independently with or without a cane or walker and are willing to commit about six months, excluding people with health problems that limit exercise such as heart issues, uncontrolled blood pressure, exercise-induced asthma, another neurologic disease, significant cognitive impairment, or very poor walking ability.
Who can participate?
Participants must be between 30 Years and 85 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 2 years.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov